Cholesterol 25-hydroxylase (CH25H) catalyses the production of 25-hydroxycholesterol (25HC) from cholesterol by adding a second hydroxyl group at position 25. The aim of this study was to examine the antiviral effect of CH25H on pseudorabies virus (PRV), a swine pathogen that can cause devastating disease and economic losses worldwide. The results showed that porcine ch25h was induced by either interferon or PRV infection. PRV infection of porcine alveolar macrophages (3D4/ 21 cells) was attenuated by CH25H overexpression and enhanced by silencing of CH25H. Furthermore, treatment of 3D4/ 21 cells with 25HC inhibited the growth of PRV in vitro, suggesting that CH25H may restrict PRV replication by 25HC production. We further identified that the anti-PRV role of CH25H and 25HC was subject to their inhibitory effect on PRV attachment and entry. Collectively, these findings demonstrate that CH25H is an intrinsic host restriction factor in PRV infection of porcine alveolar macrophages.
INTRODUCTION
Pseudorabies virus (PRV), a member of the subfamily Alphaherpesvirinae of the family Herpesviridae, is an enveloped dsDNA virus and the aetiological agent of Aujeszky's disease in pigs [1] . Although many mammals, including ruminants, carnivores and rodents, are susceptible to PRV infection [2] , the pig is the natural host, reservoir and source of this virus. PRV infection results in obvious clinical manifestations, including fever, local intense pruritus and encephalomyelitis. Since 2011, outbreaks of pseudorabies have occurred in many regions of China and the disease situation continues to worsen [3] .
The interferon (IFN)-mediated innate immune response has evolved as a robust first-line defence against invading pathogens. Pathogen associated molecular patterns are recognized by cellular pattern recognition receptors, resulting in the promotion of IFN expression and secretion [4, 5] . IFN further binds to cell surface receptors and stimulates the transcriptional regulation of hundreds of IFN-stimulated genes (ISGs), mainly via the Janus kinase signal transducer and activator of transcription pathway [6, 7] . ISGs usually play antiviral roles by influencing the entire viral life cycle through a variety of mechanisms [8] . For instance, myc-associated factor X (MaX), MX dynamin-like GTPase 2 (Mx2), IFN-induced transmembrane protein 1 (IFITM1) and tripartite motif containing protein (TRIM) preclude some mechanisms of virus entry into cells [9] [10] [11] [12] , protein kinase R inhibits translation of certain virus proteins [13] , and viperin and tetherin prevent viral egress from host cells [14, 15] . Genome-wide transcriptional profiling has identified many ISGs, yet only a handful have been studied in detail.
Cholesterol 25-hydroxylase (CH25H) catalyses 25-hydroxycholesterol (25HC) production by the oxidation of cholesterol. 25HC is well-known for its regulatory function in sterol metabolism [16] . In sterol-depleted cells, sterol regulatory element-binding proteins (SREBPs) can form a complex with SREBP cleavage-activating protein (SCAP), which facilitates release of the NH 2 -terminal domain of SREBP to activate transcription of genes involved in lipid synthesis [17] . 25HC independently binds to the endoplasmic reticulum-resident insulin-induced gene 1 protein (Insig) to form the SREBP/Insig/SCAP complex, resulting in endoplasmic reticulum retention of SREBP and inhibition of sterol biosynthesis [18, 19] .
In addition to regulation of sterol biosynthesis, 25HC also has antiviral effects [20] . Previous studies have revealed that 25HC synthesis is promoted in macrophages and dendritic cells upon exposure to IFN [21] . Moreover, MS analysis showed that murine cytomegalovirus (MCMV) infection of macrophages increases CH25H expression [22] . Based on these findings, researchers have defined that CH25H can be induced in macrophages by IFN and has the ability to inhibit replication of many viruses [20] . It has been reported that 25HC can broadly inhibit the replication of enveloped viruses, such as herpes simplex virus 1, MCMV, vesicular stomatitis virus, human immunodeficiency virus, murine gamma-herpesvirus 68 and Ebola virus [23] . 25HC also has antiviral activities against a large number of non-enveloped viruses, such as poliovirus, human papillomavirus-16, human rotavirus and human rhinovirus [24, 25] .
Since it remains uncertain whether porcine CH25H is involved in preventing PRV infection, the aim of this study was to assess the inhibitory effect of CH25H on PRV infection in porcine alveolar macrophages (3D4/21 cells). The results illustrate that porcine ch25h is an ISG and CH25H inhibits PRV replication by influencing viral entry. These findings provide new insights into the role of CH25H in the prevention of PRV infection.
RESULTS

Porcine CH25H is regulated by IFN
Previous studies have demonstrated that mouse ch25h is an ISG [23] ; thus, we attempted to determine whether porcine ch25h was also regulated by IFN and to identify the antiviral roles of this molecule in PRV infection. First, the expression of ch25h in response to IFN stimulation was evaluated. 3D4/21 cells were treated with IFN-a (100 and 1000 U ml À1 ) or IFN-b (10 and 100 U ml
À1
) for 3 h and ch25h mRNA expression was measured by quantitative PCR (qPCR) analysis. As shown in Fig. 1(a) , both IFN-a and IFN-b induced ch25h mRNA expression in a dose-dependent manner, suggesting a CH25H positive response to IFN stimulation. The expression of ISG15, which is a ubiquitinlike modifier induced by type I IFN, was also detected under the same treatment. IFN-a and IFN-b treatment dramatically enhanced ISG15 mRNA expression, which validated the function of IFN-a and -b (Fig. 1b) .
The results of our previous study demonstrated that PRV infection induced cyclic GMP-AMP synthase-dependent IFN-b expression in PK-15 cells [26] . Therefore, we examined whether IFN-b mRNA was also regulated in 3D4/ 21 cells during PRV infection. Briefly, cells were infected with PRV Bartha-K61 at an m.o.i. of 1 for 0, 3, 6, 12 and 24 h post-infection (h p.i.) and the IFN-b mRNA level was detected by qPCR. As shown in Fig. 1(c) , PRV infection for 3 and 6 h had no effect on IFN-b mRNA expression. However, when PRV infection was sustained for 12 and 24 h, IFN-b mRNA expression was significantly increased. Next, ch25h mRNA levels after PRV infection were measured by qPCR, which showed that the expression pattern of ch25h, consistent with that of IFN-b, was significantly activated by PRV infection for 12 and 24 h, but not 3 or 6 h (Fig. 1d) . These results were indicative that porcine ch25h is an ISG.
CH25H overexpression inhibits PRV replication
Sequence alignment of the catalytic residues of CH25H showed that the catalytic residues of H242 and H243, which were reported to be important for enzymatic activity [27] , are highly conserved in the human, mouse, rat and pig genomes (Fig. 2a) . We generated plasmids encoding WT or the catalytically inactive mutant (Flag-CH25H H242Q/ H243Q, mut) of CH25H to evaluate whether it is involved in anti-PRV activities. CH25H variants were overexpressed in 3D4/21 cells and expression levels were determined by immunoblot and immunofluorescence analyses. WT CH25H and the catalytically inactive mutant expressed equal amounts of protein and the intracellular expression patterns of both were diffuse (Fig. 2b, c) .
Next, the effect of CH25H overexpression on PRV replication was assessed. Cells were transfected with the pcDNA3.0 vector or plasmids encoding WT or Mut Flag-CH25H for 24 h and infected with PRV Bartha-K61 (m.o.i. of 1 and 10) for another 24 h. As shown in Fig. 2(d) , overexpression of Flag-CH25H WT, but not Flag-CH25H Mut, exhibited an inhibitory effect on PRV replication, as confirmed by virus titration. The qPCR result showed that less PRV TK and gB mRNA were transcribed in cells overexpressing Flag-CH25H, as compared to that in cells overexpressing pcDNA3 or Flag-CH25H Mut (Fig. 2e) . To further confirm the inhibitory effect of CH25H on PRV infection, PRV gB protein expression was determined by immunoblot analysis. The results indicated decreased gB protein levels in Flag-CH25H WT overexpressed cells, which further verified that CH25H could inhibit PRV infection (Fig. 2f) .
To determine whether CH25H overexpression influenced PRV attachment to the cell, CH25H overexpressing 3D4/ 21 cells were incubated with PRV Bartha-K61 (m.o.i. of 10) at 4 C for 2 h. After extensive washing to remove unbound viruses, the cell lysates were subjected to immunoblot analysis for detection of gB protein expression. As shown in Fig. 2(g) , overexpression of WT, but not Mut, Flag-CH25H, decreased PRV attachment to the cell. Collectively, these results demonstrated that CH25H overexpression inhibited PRV infection.
Knockdown of CH25H promotes PRV replication
Since the above results showed that CH25H overexpression inhibited PRV replication, we further tested whether knockdown of CH25H accelerated PRV replication. A small interfering RNA (siRNA) control (siControl) or three distinct siRNAs (siCH25H-1, 2 and 3) targeting CH25H mRNA were transfected into 3D4/21 cells for 48 h and the knockdown efficiency was assessed by qPCR. Two siRNAs, siCH25H-1 and siCH25H-3, exhibited higher knockdown efficiency of CH25H (~60 % respectively), as compared to siControl and siCH25H-2 (Fig. 3a) .
So siCH25H-1 and siCH25H-3 were used for the following investigation.
Cells were transfected with siControl, siCH25H-1, siCH25H-3 or siCH25H-1/3 for 48 h and then infected with PRV Bartha-K61 (m.o.i. of 0.1) for 24 h. Then, PRV replication in cells after CH25H knockdown was determined. As shown in Fig. 3(b) , the virus titre was higher in cells transfected with siCH25H-1, siCH25H-3 and siCH25H-1/3 than with siControl. Immunoblot and qPCR analyses of TK and gB expression also confirmed that PRV replication was enhanced in CH25H knockdown cells (siCH25H-1, siCH25H-3 and siCH25H-1/ 3), as compared with control cells, as indicated in Fig. 3(c, d) . Collectively, these results suggested that knockdown of CH25H enhanced PRV replication.
25HC prevents PRV replication
To explore whether 25HC was also responsible for the antiviral activity against PRV as CH25H, 3D4/21 cells were treated with 25HC and PRV replication was examined. Cell viability was first assayed to determine the cytotoxicity of 25HC using cell counting kit-8 (CCK-8). As shown in Fig. 4 (a), treatment with 0.6, 2, 6 and 20 µM 25HC for 12 and 24 h exhibited no toxicity to 3D4/21 cells. However, significant toxic effects were observed when cells were treated with 6 and 20 µM 25HC for 48 h. 
25HC disturbs PRV attachment and entry
To gain insight into the mechanisms of 25HC inhibition of PRV infection, the growth kinetics of PRV Bartha-K61 were investigated. 3D4/21 cells were infected with PRV Bartha-K61 (m.o.i. of 10). At each hour following infection, both the cells and culture medium were titrated using the TCID 50 assay. As shown by the one-step growth curve, both the intracellular and extracellular infectious PRV particles were first detected at 4 h p.i. (Fig. 5a) .
Then, the ability of 25HC to inhibit PRV attachment was examined. Briefly, 3D4/21 cells were incubated with PRV Bartha-K61 (m.o.i. of 10) and different concentrations of 25HC at 4 C for 2 h. After extensive washing to remove unbound viruses, the cell lysates were subjected to immunoblot analysis for detection of gB protein expression. As shown in Fig. 5(b) , 25HC reduced the amount of attached virus in a dose-dependent manner, as demonstrated by decreased gB protein expression. Similar results of dosedependent inhibition of virus attachment were also observed, as demonstrated by qPCR of the viral genome (Fig. 5c) . These results suggested that 25HC inhibited PRV attachment.
Finally, the ability of 25HC to inhibit PRV entry was investigated. Briefly, 3D4/21 cells were incubated with PRV Bartha-K61 (m.o.i. of 10) and different concentrations of 25HC at 4
C for 1 h. After internalization for 1 h, immunoblot and qPCR analyses were performed to examine gB protein expression and the viral genome. Consistent with the effect of 25HC on PRV attachment, the addition of 25HC inhibited PRV entry in a dose-dependent manner (Fig. 5d, e) . Collectively, these results suggested that 25HC inhibited PRV infection by influencing viral attachment and entry.
DISCUSSION
The antiviral effect of 25HC against a broad spectrum of viruses (enveloped and non-enveloped) expands our knowledge of its well-known function in sterol feedback regulation [20] . CH25H expression and 25HC production are increased in macrophages infected with MCMV or treated with some inflammatory cytokines [21, 22] . Liu et al. [23] have suggested that murine ch25h is strongly induced by IFN-a (type I IFN) and IFN-g (type II IFN) in murine bone marrow-derived macrophages. The results of the present study showed that porcine ch25h was induced by type I IFN (IFN-a and IFN-b) and IFN-g promoted CH25H expression in 3D4/21 cells (data not shown). The key catalytic residues required for the enzymatic activity of CH25H have been shown to be highly conserved among different species. These findings, combined with those of previous studies, demonstrate that CH25H is an evolutionarily conserved ISG.
In addition to 25HC, other oxysterols also have antiviral activity in vitro. For instance, 27HC inhibits infection of several viruses, such as MCMV, human papillomavirus-16 and human rhinovirus [25] . Intriguingly, 27-hydroxylase expression does not respond to IFN stimulation [28] , suggesting different mechanisms of 25HC and 27HC against viral infection. Unpublished observations from our studies revealed that 27HC exhibits faintly antiviral activity against PRV infection (data not shown). Hence, it is interesting and important to unveil the detailed mechanisms of other oxysterols involved in PRV infection.
By overexpression and knockdown analysis, CH25H was identified as a host restriction factor in PRV infection. The results of the present study demonstrated that 25HC not only inhibited the attachment of the virulent PRV isolate QXX in 3D4/21 cells, but also PRV vaccine strain Bartha-K61. The expressions of a series of enzymes involved in sterol biosynthesis in 3D4/21 cells treated with 25HC were investigated by qPCR. As shown in Fig. S1 (available in the online Supplementary Material), the expression levels of enzymes of fatty acid (ACC, FAS and SREBP1) and cholesterol (HMGCR, HMGCS and SREBP2) synthesis were all decreased in response to 25HC. Diminished sterol synthesis may alter lipid distribution in the cell membrane. Plasma membrane cholesterol is required for efficient PRV entry, and depletion of cholesterol in the cell membrane prevents the formation of lipid rafts and inhibits PRV entry [29] . Liu and colleagues suggested that 25HC blocks vesicular stomatitis virus entry by directly modifying the cell membrane [23] . 25HC may influence PRV attachment by disturbing the association between PRV envelop proteins and lipid rafts.
Chen et al. [30] revealed that not only the WT, but also the catalytic inactive form of CH25H, inhibited hepatitis C virus (HCV) replication through interactions with HCV NS5A protein to interfere with NS5A dimer formation, which is required for HCV replication. The antiviral effect of CH25H against PRV may not be due to this mechanism, as PRV replication was not significantly reduced in cells overexpressing the catalytic inactive form of CH25H (Fig. 2d) . Of note, it has been demonstrated that challenge of cells with 25HC activates the integrated stress response and suppresses cellular protein synthesis, which leads to inhibition of virus replication [22] . Moreover, Blanc et al. [28] suggested that MCMV protein Virus titre was determined as described in (b). *, P<0.05; **, P<0.01 (f) 25HC attenuated PRV QXX gB protein expression. 3D4/21 cells were treated as described in (e). Immunoblot analysis was performed as described in (d).
expression was decreased in macrophages treated with 25HC. Therefore, we hypothesized that 25HC inhibited PRV infection not only by inhibiting viral gene transcription, but also by decreasing viral protein synthesis. In summary, we first identified that porcine CH25H is an intrinsic restriction factor in PRV replication that exerted its suppressive function on PRV replication possibly via 25HC production, all of which will help to develop new strategies to prevent PRV infection.
METHODS
Cells, viruses and tissues 3D4/21 (porcine alveolar macrophage) and Vero (kidney epithelial cells from Cercopithecus aethiops) cells were cultured in Dulbecco's modified Eagle's medium (DMEM) (Gibco) containing 10 % (v/v) FBS (Gibco). The attenuated PRV vaccine strain Bartha-K61 was used as previously mentioned [26] . The virulent PRV isolate QXX was kindly donated by Yong-Tao Li from the College of Animal Sciences and Veterinary Medicine, Henan Agricultural University [31] .
Plasmids and transient transfection
The coding sequence of porcine CH25H was cloned into p3ÂFlag-CMV-10 (Sigma-Aldrich) with the endonucleases HindIII and BamHI (New England Biolabs). Point mutations in the catalytic residues of CH25H (H242Q and H243Q) were generated by site-directed mutagenesis (Stratagene). The oligo-DNA primers are listed in Table 1 . C for 2 h. Immunoblot (b) and qPCR analyses (c) were performed to detect gB protein and PRV genome (with primers Q-TK F/R shown in Table 1 ). *, P<0.05; **, P<0.01 (d, e) 25HC inhibited PRV entry. 3D4/21 cells were infected with PRV Bartha-K61 (m.o.i. of 10) along with the indicated concentrations of 25HC at 4 C for 1 h. After washing and viral internalization for 1 h, immunoblot (d) and qPCR analyses (e) were performed to detect gB protein and PRV genome (with the primers Q-TK F/R shown in Table 1 ). *, P<0.05; **, P<0.01.
Cells were transiently transfected with Fugene HD (Promega), according to the manufacturer's instructions. qPCR Total RNA was extracted from cells using TRIzol Reagent (Takara Bio) and reverse transcribed into cDNA using the PrimeScript RT reagent kit with gDNA Eraser (Takara Bio). qPCR was performed with the primers listed in Table 1 and SYBR Premix Ex Taq (Takara Bio) using the Mastercycler ep realplex system (Eppendorf). The relative amounts of mRNA were calculated using the comparative cycle threshold method. Porcine actin was used as an internal control to normalize gene expression levels. Each assay was performed in triplicate.
RNA interference siRNAs targeting different sequences of ch25h mRNA were designed using the BLOCK-iT RNAi designer kit (Life Technologies) and commercially synthesized by Shanghai GenePharma. Briefly, 3D4/21 cells were grown to 70-80 % confluence in six-well plates and then transiently transfected with siRNAs (Table 2) using Lipofectamine RNAiMAX transfection reagent (Invitrogen), according to the manufacturer's instructions. The knockdown efficiency was measured by qPCR. Each assay was performed in triplicate.
Immunoblot analysis
Total cell extracts were prepared using radioimmunoprecipitation assay lysis buffer [50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1 % Triton X-100, 1 % sodium deoxycholate, 0.1 % SDS, 2 mM MgCl 2 ] supplemented with protease and phosphatase inhibitors (Roche Diagnostics Deutschland). After centrifugation at 13 200 r.p.m. for 20 min at 4 C, the supernatant was harvested and the protein concentration was quantified with a bicinchoninic acid protein assay kit (Beijing DINGGUO Biotechnology). Protein samples (50 µg) were separated by SDS-PAGE with 10 % gels, transferred to nitrocellulose membranes (Millipore) and blocked with 5 % non-fat milk (Sangon Biotech) at room temperature for 1 h. The membranes were incubated with primary antibody solution against the target protein at 4 C overnight. After washing three times with TBS buffer, the membranes were incubated with HRP-conjugated secondary antibodies at a dilution of 1 : 5000 (Jackson Immuno Research Laboratories) at room temperature for 1 h. The target proteins were detected using Luminata Crescendo Western HRP substrate (Millipore) and the blots were exposed to film (Eastman Kodak). Each assay was performed in triplicate.
Immunofluorescence assay Cells grown on glass coverslips (Thermo Fisher Scientific) were fixed with 4 % paraformaldehyde for 20 min. After washing with PBS, the cells were permeabilized with PBS containing 0.2 % Triton X-100 for 5 min and then incubated in PBS/10 % FBS for 30 min. Flag was detected by incubating cells in PBS/10 % FBS containing anti-Flag M2 mouse mAb (1 : 500; Sigma-Aldrich) for 1 h. After washing with PBS, the cells were further incubated with fluorescent secondary antibodies (1 : 500; Invitrogen) in PBS/ 10 % FBS for 1 h. Immunofluorescence microscopy was conducted using an IX73 microscope (Olympus).
Cell viability assay
The CCK-8 cell counting kit (Beijing DINGGUO Biotechnology) was used to analyse cell viability after treatment with 25HC (Steraloids). On day 0, 3D4/21 cells were seeded at a density of 1Â10 4 cells per well. On day 1, the medium was 
Virus titration and infection
The TCID 50 assay was performed to assess virus titration and infectivity. On day 0, Vero cells were seeded in a 96-well plate at a density of 1Â10 4 cells per well. On day 1, the cells were inoculated with serially diluted viruses (10 À1 -10 À12 fold) at 37 C for 1 h. The excess virus inoculum was removed by washing with PBS. Then, 200 µl maintenance medium (DMEM/2 % FBS) was added to each well and the cells were further cultured for 3-5 days. The cells demonstrating the expected cytopathic effect were observed daily and the TCID 50 value was calculated by the Reed-Muench method. Each assay was performed in triplicate.
Statistical analysis
The results are presented as the mean ± SD. Student's t-test was used to determine the statistical significance of differences between experimental groups. The criteria for statistical significance were: *, P<0.05; and **, P <0.01, respectively. 
